1. US rules out bailout for Silicon Valley Bank, auctions reportedly underway 2. Apple CEO Tim Cook backs AR/VR headset, likely to launch this year 3. Infosys’ Mohit Joshi joins Tech Mahindra as MD and CEO

RIVM – Quality of protective equipment insufficient during COVID-19 crisis

Spread the love

The personal protective equipment (PPE) purchased at the national level during the COVID-19 crisis for use in the healthcare sector only partly met the required standards of quality.

These findings are from research conducted by RIVM, which included testing of various personal protective equipment between March and October 2020.

In particular, the quality of respiratory protection devices (FFP2 and KN95 respirator masks) and surgical face masks (type IIR) was insufficient.

Only 22% of the FFP2 and KN95 masks and 14% of the Type IIR masks were fully compliant with PPE requirements.
For example, respirator masks were not always properly fitted; without a good seal on the face, they provided insufficient protection against virus particles. In addition, the isolation gowns and gloves tested by RIVM were not always waterproof.

Claim Free Bets

Moreover, product quality sometimes varied significantly within the same batch, even though the products were the same according to the description on the packages.

No full assessment procedure

RIVM tested and assessed the products at the request of the Ministry of Health, Welfare and Sport (VWS). This happened between March and October 2020. Due to the severe shortages, there was no time for a full assessment procedure during that period.

Working with various parties, an abbreviated assessment procedure was therefore set up which approximated the prevailing standards as closely as possible.

The procedure has undergone further development along the way.

Quality assessments as advisory input for LCH

The quality assessments were provided as advisory reports to the Ministry of Health, Welfare and Sport, and later to the National Consortium for Medical Devices (LCH). Due to the shortages, LCH purchased these medical products centrally for the Netherlands.

LCH decisions on purchase and distribution of the products were based in part on the advisory reports from RIVM. LCH determined which products were assessed by RIVM. In total, RIVM assessed approximately 2,500 batches provided by LCH.

Source link-



    Ankita Deshkar

    All Posts

    Related Post

    View All

    Celebrations of 73rd Republic Day of India at India ...

    January 27th, 2022 | Ankita Deshkar

    Spread the loveAmbassador Pradeep Kumar hoisted the Indian flag at India House, Wassenaar at the 73rd Republic Day Celebra...

    RIVM: Omikron decline continues, virus on all fronts...

    February 23rd, 2022 | Ankita Deshkar

    Spread the loveThe impact of omikron is decreasing in the Netherlands on all fronts. Last week, RIVM reported 301,144 posi...

    Doctors from UMC Utrecht successfully implant first ...

    November 15th, 2021 | Ankita Deshkar

    Spread the love The operation is part of a long-term and international research project to find a reliable alternative to ...